Results 41 to 50 of about 2,061,103 (249)
Early administration of thrombolytic agents is standard for patients presenting with acute myocardial infarction (MI). Also, prolonged QT intervals indicate a higher risk for sudden death in patients with MI.
Reza Ghasemi +3 more
doaj +1 more source
Background: Late revascularization following a myocardial infarction has questionable clinical benefit. Methods: We studied 13 patients with anterior wall myocardial infarction who underwent percutaneous coronary intervention within 2 weeks of the ...
Srilakshmi M Adhyapak +5 more
doaj +1 more source
Myocardial infarction of interior wall: a case study
Cardiovascular diseases are the primary death factors of people in the world. Myocardial infarctions and strokes are the most predominant among them. Securing a patient with myocardial infarction requires a rapid pre-hospital procedure and a fast cardiac
Paweł Musiał +4 more
core +1 more source
Intelligent Micro/Nanorobots for Targeted Interventional Therapy: From Bench to Clinic
Zirui Zhang et al. reviewed the application and challenges of mobile nanomachines in interventional therapy. By converting exogenous energy, including chemical, magnetic, optical, and ultrasonic sources, into mechanical forces, micro/nanorobots (MNRs) enable precise actuation at unprecedented scales. Evolving far beyond traditional drug delivery, these
Zirui Zhang +5 more
wiley +1 more source
Optimising coronary reperfusion in acute myocardial infarction: the role of primary angioplasty [PDF]
PhDThrombolysis remains the predominant reperfusion strategy for ST segment elevation myocardial infarction (STEMI) in the United Kingdom. Although primary angioplasty may offer superior outcomes, the logistics of delivering this therapy in the UK ...
Smith, Elliot J
core +4 more sources
Introduction Myocardial infarction with non-obstructive coronary arteries (MINOCA), tako-tsubo cardiomyopathy (TTC), infective myocarditis (IM) and acute ST-segment elevation myocardial infarction (STEMI) of anterior wall being a heterogeneous group ...
Magdalena Jędrychowska +8 more
doaj +1 more source
Cell‐Based Biohybrid Micro/Nanorobots for Biotherapy
This review systematically evaluates cell‐based biohybrid micro/nanorobots (CB‐BMRs), highlighting their cell selection criteria, fabrication strategies, and diverse actuation modes. Furthermore, it surveys the promising therapeutic applications of CB‐BMRs in targeted cancer, thrombosis, and inflammation treatments, while comprehensively discussing ...
Lin Wang +11 more
wiley +1 more source
Long-term mortality after first Acute Myocardial Infarction in the light of changing therapeutic guidelines and diagnostic criteria between 1995 and 2003 [PDF]
Background: The introduction of new invasive therapies for acute myocardial infarction and new medication schemes for secondary prevention is thought to increase life expectancy in 28-day survivors of a first myocardial infarction.
Kandler, Ulla
core +1 more source
A Novel Pak1 Activator Ameliorates ER Stress for HFpEF Therapy
Chronic metabolic stress is a major contributor to HFpEF progression. Under prolonged metabolic stress, Pak1 activity becomes impaired, contributing to disrupted ER proteostasis, cardiomyocyte apoptosis, fibrosis, and diastolic dysfunction. Mechanistically, Pak1 overexpression activates the ERK1/2–MNK1–eIF4E signaling axis, promotes translational ...
Honglin Xu +17 more
wiley +1 more source
A Study of Arrhythmias in First 48 Hours of Acute Myocardial Infarction in a Tertiary Care Hospital [PDF]
Introduction: Myocardial infarction is defined as a clinical or pathologic event caused by myocardial ischemia in which there is evidence of myocardial injury or necrosis. The diagnosis of myocardial infarction is established by typical symptoms, cardiac
Mohini Singh +2 more
doaj +1 more source

